Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
Journal of Radiation Research · 2023
DOI: 10.1093/jrr/rrad064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, 2023. Verfasst von Yoshihide Hattori und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for BNCT, Osaka Metropolitan University, 1-1 Gakuen-cho, Nakaku, Sakai 599-8531, Japan. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Head and Neck Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka Metropolitan University.
Abstract (Originalsprache)
Recently, boron neutron capture therapy (BNCT) has been attracting attention as a minimally invasive cancer treatment. In 2020, the accelerator-based BNCT with L-BPA (Borofalan) as its D-sorbitol complex (Steboronine®) for head and neck cancers was approved by Pharmaceutical and Medical Devices Agency for the first time in the world. As accelerator-based neutron generation techniques are being developed in various countries, the development of novel tumor-selective boron agents is becoming increasingly important and desired. The Japanese Society of Neutron Capture Therapy believes it is necessary to propose standard evaluation protocols at each stage in the development of boron agents for BNCT. This review summarizes recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for BNCT based on our experience with L-BPA approval.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for BNCT, Osaka Metropolitan University, 1-1 Gakuen-cho, Nakaku, Sakai 599-8531, Japan.
- Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe 650-8586, Japan.
- Department of Neurosurgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki-shi, Osaka 569-8686, Japan.
- Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki-shi, Osaka 569-8686, Japan.
- Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2, Asashiro-Nishi, Kumatori-cho, Sennan-gun 590-0494 Japan.
- Neutron Therapy Research Center, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
Förderung
- Osaka Metropolitan University
Zitieren
APA
Hattori, Y., Andoh, T., Kawabata, S., Hu, N., Michiue, H., Nakamura, H., Nomoto, T., Suzuki, M., Takata, T., Tanaka, H., Watanabe, T., & Ono, K. (2023). Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrad064
Vancouver
Hattori Y, Andoh T, Kawabata S, Hu N, Michiue H, Nakamura H, et al. Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy. Journal of Radiation Research. 2023. doi:10.1093/jrr/rrad064
BibTeX
@article{Hattori2023,
author = {Hattori, Yoshihide and Andoh, Tooru and Kawabata, Shinji and Hu, Naonori and Michiue, Hiroyuki and Nakamura, Hiroyuki and Nomoto, Takahiro and Suzuki, Minoru and Takata, Takushi and Tanaka, Hiroki and Watanabe, Tsubasa and Ono, Koji},
title = {Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy},
journal = {Journal of Radiation Research},
year = {2023},
doi = {10.1093/jrr/rrad064}
}
EUVIMED